Walleye Trading LLC Anavex Life Sciences Corp. Put Options Transaction History

Walleye Trading LLC

7 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q4 2023 Feb 14, 2024	BUY	$5.04 - $9.95 $60,480 - $119,399	12,000 New	12,000 $111,000
Q2 2023 Aug 14, 2023	SELL	$7.66 - $9.5 $21,448 - $26,600	-2,800 Reduced 47.46%	3,100 $25,000
Q1 2023 May 15, 2023	BUY	$8.32 - $11.75 $49,088 - $69,325	5,900 New	5,900 $50,000
Q1 2022 May 16, 2022	BUY	$9.74 - $17.69 $212,332 - $385,642	21,800 New	21,800 $268,000
Q4 2021 Feb 14, 2022	SELL	$16.88 - $23.31 $118,160 - $163,170	-7,000 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$16.82 - $25.75 $299,396 - $458,350	-17,800 Reduced 71.77%	7,000 $126,000
Q2 2021 Aug 16, 2021	BUY	$10.16 - $28.86 $251,968 - $715,728	24,800 New	24,800 $567,000

155

27.3M

515K

838K

Ticker AVXL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,942,800
Market Cap $673M
Description
Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial for the treatment of Alzheimer's disease; Phase III clinical trial to treat pediatric patien...

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Trading LLC with notifications on news.